Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

• Status: Withdrawn
• Trial end date: 2013-12-01

Summary

The current study is initiated in order to assess the impact of a PD solution containing L-carnitine on insulin sensitivity evaluated by measuring insulin requirement.

• Phase: Phase 2

Details

• Lead Sponsor: Iperboreal Pharma Srl
• Treatments: Insulin; Pharmaceutical Solutions